Total Payments
$39,518
2024 Payments
$994.52
Companies
16
Transactions
68
Medicare Patients
17,597
Medicare Billing
$13.1M
Payment Breakdown by Category
Consulting$32,472 (82.2%)
Other$5,066 (12.8%)
Food & Beverage$1,805 (4.6%)
Gifts$175.63 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,472 | 11 | 82.2% |
| Acquisitions | $2,772 | 1 | 7.0% |
| Food and Beverage | $1,805 | 40 | 4.6% |
| Current or prospective ownership or investment interest | $1,560 | 6 | 3.9% |
| Grant | $500.15 | 1 | 1.3% |
| Honoraria | $234.83 | 2 | 0.6% |
| Gift | $175.63 | 1 | 0.4% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$39,518
62 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $32,472 | 11 | $0 (2023) |
| US Retina LLC | $4,331 | 13 | $0 (2022) |
| NotalVision | $521.87 | 4 | $0 (2017) |
| ABBVIE INC. | $500.15 | 1 | $0 (2024) |
| Harrow Eye, LLC | $364.58 | 1 | $0 (2024) |
| Genentech USA, Inc. | $324.40 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $259.15 | 4 | $0 (2022) |
| TissueTech, Inc. | $221.38 | 2 | $0 (2018) |
| Carl Zeiss Meditec, Inc. | $175.63 | 1 | $0 (2020) |
| Allergan Inc. | $117.55 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $994.52 | 9 | ABBVIE INC. ($500.15) |
| 2023 | $32,236 | 9 | Baxter Healthcare ($32,167) |
| 2022 | $3,929 | 13 | US Retina LLC ($3,437) |
| 2021 | $435.09 | 5 | US Retina LLC ($371.42) |
| 2020 | $382.04 | 3 | US Retina LLC ($206.41) |
| 2019 | $478.43 | 7 | US Retina LLC ($316.00) |
| 2018 | $207.46 | 8 | TissueTech, Inc. ($99.03) |
| 2017 | $856.16 | 14 | NotalVision ($521.87) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/20/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $364.58 | General |
| Category: OPTOMETRY | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/27/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Ophthalmology | ||||||
| 04/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Grant | Cash or cash equivalent | $500.15 | General |
| Category: EYE CARE | ||||||
| 02/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/08/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $31,786.50 | General |
| Category: Physical Assessment, Vision | ||||||
| 12/08/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 10/13/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $140.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 08/17/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $28.68 | General |
| 08/03/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/16/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $110.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 04/05/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/10/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $75.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 01/20/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $5.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 12/16/2022 | US Retina LLC | — | Acquisitions | Cash or cash equivalent | $2,771.54 | General |
| 10/06/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $105.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 08/24/2022 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $35.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 08/01/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $25.73 | General |
| 07/06/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $45.00 | General |
| Category: Physical Assessment, Vision | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,148 | 10,388 | $8.1M | $2.5M |
| 2022 | 13 | 4,428 | 12,956 | $9.6M | $3.3M |
| 2021 | 15 | 5,112 | 14,835 | $10.7M | $3.8M |
| 2020 | 14 | 4,909 | 13,681 | $9.7M | $3.4M |
Total Patients
17,597
Total Services
51,860
Medicare Billing
$13.1M
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 278 | 2,446 | $4.9M | $1.7M | 34.7% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 61 | 840 | $840,000 | $182,209 | 21.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 377 | 1,425 | $783,750 | $141,792 | 18.1% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 34 | 1,125 | $378,000 | $135,388 | 35.8% |
| J3490 | Unclassified drugs | Office | 2023 | 33 | 64 | $322,370 | $116,406 | 36.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 411 | 855 | $230,850 | $90,609 | 39.3% |
| 92134 | Imaging of retina | Office | 2023 | 763 | 1,995 | $249,375 | $57,199 | 22.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 451 | 573 | $151,845 | $49,053 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 261 | 417 | $112,590 | $33,942 | 30.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 53 | 163 | $24,450 | $8,996 | 36.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 88 | 88 | $27,720 | $8,422 | 30.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 94 | 117 | $22,230 | $7,264 | 32.7% |
| 92250 | Photography of the retina | Office | 2023 | 202 | 236 | $22,420 | $5,925 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,000 | $2,662 | 38.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 22 | 24 | $3,600 | $911.40 | 25.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 385 | 3,724 | $7.4M | $2.7M | 35.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 475 | 1,855 | $1.0M | $180,797 | 17.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 674 | 1,354 | $270,800 | $128,748 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 437 | 1,224 | $183,600 | $108,776 | 59.2% |
| 92134 | Imaging of retina | Office | 2022 | 1,032 | 2,622 | $222,870 | $73,273 | 32.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 574 | 720 | $144,000 | $60,413 | 42.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 13 | 241 | $194,600 | $53,817 | 27.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 82 | 351 | $36,550 | $18,712 | 51.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 176 | 176 | $35,200 | $18,011 | 51.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 163 | 217 | $32,550 | $12,590 | 38.7% |
About Dr. Mark Levitan, MD
Dr. Mark Levitan, MD is a Ophthalmology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609848399.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Levitan, MD has received a total of $39,518 in payments from pharmaceutical and medical device companies, with $994.52 received in 2024. These payments were reported across 68 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($32,472).
As a Medicare-enrolled provider, Levitan has provided services to 17,597 Medicare beneficiaries, totaling 51,860 services with total Medicare billing of $13.1M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Austin, TX
- Active Since 02/06/2006
- Last Updated 05/04/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1609848399
Products in Payments
- Hillrom - RetinaVue 700 Imager (Device) $32,472
- OZURDEX (Drug) $617.70
- ForeseeHome (Device) $521.87
- IHEEZO (Drug) $364.58
- BEOVU (Drug) $240.70
- Lucentis (Biological) $230.45
- Prokera (Device) $221.38
- CLARUS (Device) $175.63
- Vabysmo (Drug) $68.22
- EYLEA HD (Biological) $49.01
- CVI Systems (Device) $45.00
- EYLEA (Biological) $32.49
- Izervay (Drug) $20.57
- ILUVIEN (Drug) $19.66
- (820) Cholbam (Drug) $19.31
- ACTHAR (Biological) $15.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Austin
Vikram Durairaj, Md, MD
Ophthalmology — Payments: $516,103
Ophthalmology $516,103
Dr. Sheila Barbarino, M.d, M.D
Ophthalmology — Payments: $236,894
Ophthalmology $236,894
Dr. Thomas Walters, Md, MD
Ophthalmology — Payments: $217,539
Ophthalmology $217,539
Chirag Jhaveri, M.d, M.D
Ophthalmology — Payments: $211,408
Ophthalmology $211,408
Dr. Steven Dell, M.d, M.D
Ophthalmology — Payments: $177,840
Ophthalmology $177,840
Dr. Aaron Roller, M.d, M.D
Ophthalmology — Payments: $154,063
Ophthalmology $154,063